As of the latest Form 4 filed May 11, 2026.
What HCA Healthcare, Inc. insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 57 most recent filings for HCA.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | 2026-05-07 | Marks Mike A EVP and CFO | GGift | +3.34K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-11 | 2026-05-07 | Marks Mike A, EVP and CFO | GGift | −3.34K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-30 | 2026-04-28 | Smith Andrea B Director | AAward | +509.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-30 | 2026-04-28 | Riley Wayne Joseph Director | AAward | +509.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-30 | 2026-04-28 | MICHELSON MICHAEL W Director | AAward | +925.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-30 | 2026-04-28 | Johnston Hugh F Director | AAward | +809.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-30 | 2026-04-28 | DEPARLE NANCY ANN Director | AAward | +509.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-30 | 2026-04-28 | CHIDSEY JOHN Director | AAward | +809.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-30 | 2026-04-28 | Frist William R Director | AAward | +809.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-30 | 2026-04-28 | FRIST THOMAS F III Director | AAward | +1.04K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-12 | 2026-02-11 | Wyatt Christopher F. SVP & Controller | SSale | −4.00K | $505.00 | $2.02M | No | Form 4 ↗ |
| 2026-02-12 | 2026-02-11 | Berres Jennifer SVP & Chief Human Res. Officer | SSale | −4.01K | $526.16 | $2.11M | No | Form 4 ↗ |
| 2026-02-12 | 2026-02-11 | Berres Jennifer, SVP & Chief Human Res. Officer | SSale | −4.01K | $503.00 | $2.02M | No | Form 4 ↗ |
| 2026-02-12 | 2026-02-10 | Wyatt Christopher F. SVP & Controller | FTax | −1.03K | $502.05 | $519K | No | Form 4 ↗ |
| 2026-02-12 | 2026-02-10 | Wyatt Christopher F., SVP & Controller | AAward | +3.35K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-12 | 2026-02-10 | Rossitto Erica SVP & Chief Nurse Executive | FTax | −418.00 | $502.05 | $210K | No | Form 4 ↗ |
| 2026-02-12 | 2026-02-10 | Rossitto Erica, SVP & Chief Nurse Executive | AAward | +1.68K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-12 | 2026-02-10 | McAlevey Michael R EVP & Chief Legal & Admin Off. | FTax | −3.01K | $502.05 | $1.51M | No | Form 4 ↗ |
| 2026-02-12 | 2026-02-10 | McAlevey Michael R, EVP & Chief Legal & Admin Off. | AAward | +8.37K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-12 | 2026-02-10 | Marks Mike A EVP and CFO | FTax | −1.69K | $502.05 | $848K | No | Form 4 ↗ |
| 2026-02-12 | 2026-02-10 | Marks Mike A, EVP and CFO | AAward | +5.03K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-12 | 2026-02-10 | HAZEN SAMUEL N CEO | FTax | −21.3K | $502.05 | $10.7M | No | Form 4 ↗ |
| 2026-02-12 | 2026-02-10 | HAZEN SAMUEL N, CEO | AAward | +54.9K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-12 | 2026-02-10 | Foster Jon M EVP and COO | FTax | −5.89K | $502.05 | $2.96M | No | Form 4 ↗ |
| 2026-02-12 | 2026-02-10 | Foster Jon M, EVP and COO | AAward | +15.7K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-12 | 2026-02-10 | Cuffe Michael S. EVP and Chief Clinical Officer | FTax | −3.50K | $502.05 | $1.76M | No | Form 4 ↗ |
| 2026-02-12 | 2026-02-10 | Cuffe Michael S., EVP and Chief Clinical Officer | AAward | +9.63K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-12 | 2026-02-10 | Berres Jennifer SVP & Chief Human Res. Officer | FTax | −2.52K | $502.05 | $1.26M | No | Form 4 ↗ |
| 2026-02-12 | 2026-02-10 | Berres Jennifer, SVP & Chief Human Res. Officer | AAward | +7.12K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-10 | 2026-02-06 | FRIST THOMAS F JR 10% owner | JOther | +36.6M | — | — | No | Form 4 ↗ |
| 2026-02-10 | 2026-02-06 | FRIST THOMAS F JR, 10% owner | JOther | −36.6M | — | — | No | Form 4 ↗ |
| 2026-02-10 | 2026-02-06 | Frist William R Director | JOther | +36.6M | — | — | No | Form 4 ↗ |
| 2026-02-10 | 2026-02-06 | Frist William R, Director | JOther | −36.6M | — | — | No | Form 4 ↗ |
| 2026-02-10 | 2026-02-06 | FRIST THOMAS F III Director | JOther | +36.6M | — | — | No | Form 4 ↗ |
| 2026-02-10 | 2026-02-06 | FRIST THOMAS F III, Director | JOther | −36.6M | — | — | No | Form 4 ↗ |
| 2026-02-10 | 2026-02-06 | Elcan Patricia F 10% owner | JOther | +36.6M | — | — | No | Form 4 ↗ |
| 2026-02-10 | 2026-02-06 | Elcan Patricia F, 10% owner | JOther | −36.6M | — | — | No | Form 4 ↗ |
| 2026-02-10 | 2026-02-06 | HERCULES HOLDING II 10% owner | JOther | −36.6M | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-10 | 2026-02-06 | Frisco Holding II 10% owner | JOther | +36.6M | — | — | No | Form 4 ↗ |
| 2026-02-10 | 2026-02-06 | Frisco Holding II, 10% owner | JOther | −36.6M | — | — | No | Form 4 ↗ |
| 2026-02-09 | 2026-02-05 | Wyatt Christopher F. SVP & Controller | FTax | −5.67K | $513.76 | $2.92M | No | Form 4 ↗ |
| 2026-02-09 | 2026-02-05 | Wyatt Christopher F., SVP & Controller | MExercise | +10.7K | $139.06 | $1.48M | No | Form 4 ↗ |
| 2026-02-09 | 2026-02-05 | Foster Jon M EVP and COO | FTax | −16.1K | $513.76 | $8.26M | No | Form 4 ↗ |
| 2026-02-09 | 2026-02-05 | Foster Jon M, EVP and COO | MExercise | +29.3K | $139.06 | $4.08M | No | Form 4 ↗ |
| 2026-02-05 | 2026-02-04 | HAZEN SAMUEL N CEO | JOther | +1.04K | $498.35 | $521K | No | Form 4 ↗ |
| 2026-02-05 | 2026-02-04 | HAZEN SAMUEL N, CEO | JOther | −1.04K | $498.35 | $521K | No | Form 4 ↗ |
| 2026-02-05 | 2026-02-03 | HAZEN SAMUEL N, CEO | SSale | −120.00 | $497.18 | $59.7K | No | Form 4 ↗ |
| 2026-02-05 | 2026-02-03 | HAZEN SAMUEL N, CEO | SSale | −4.29K | $498.12 | $2.14M | No | Form 4 ↗ |
| 2026-02-05 | 2026-02-03 | HAZEN SAMUEL N, CEO | SSale | −5.16K | $498.80 | $2.57M | No | Form 4 ↗ |
| 2026-02-05 | 2026-02-03 | HAZEN SAMUEL N, CEO | SSale | −6.19K | $500.02 | $3.09M | No | Form 4 ↗ |
| 2026-02-05 | 2026-02-03 | HAZEN SAMUEL N, CEO | SSale | −7.39K | $500.69 | $3.70M | No | Form 4 ↗ |
| 2026-02-05 | 2026-02-03 | HAZEN SAMUEL N, CEO | SSale | −5.00K | $502.15 | $2.51M | No | Form 4 ↗ |
| 2026-02-05 | 2026-02-03 | HAZEN SAMUEL N, CEO | SSale | −14.7K | $502.95 | $7.40M | No | Form 4 ↗ |
| 2026-02-05 | 2026-02-03 | Cuffe Michael S. EVP and Chief Clinical Officer | GGift | −4.05K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-05 | 2026-02-03 | Cuffe Michael S., EVP and Chief Clinical Officer | SSale | −1.50K | $498.09 | $747K | No | Form 4 ↗ |
| 2026-02-02 | 2026-01-30 | HAZEN SAMUEL N CEO | FTax | −41.5K | $488.27 | $20.3M | No | Form 4 ↗ |
| 2026-02-02 | 2026-01-30 | HAZEN SAMUEL N, CEO | MExercise | +84.4K | $81.96 | $6.91M | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also HCA’s full analysis or the market-wide insider trading feed. The tabs above jump to HCA’s other SEC data.
Source: SEC Form 4 filings for HCA, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.